TY - JOUR
T1 - HbA1c, fasting and 2 h plasma glucose in current, ex- and never-smokers
T2 - A meta-analysis
AU - Soulimane, Soraya
AU - Simon, Dominique
AU - Herman, William H.
AU - Lange, Celine
AU - Lee, Crystal M Y
AU - Colagiuri, Stephen
AU - Shaw, Jonathan E.
AU - Zimmet, Paul Z.
AU - Magliano, Dianna
AU - Ferreira, Sandra R G
AU - Dong, Yanghu
AU - Zhang, Lei
AU - Jorgensen, Torben
AU - Tuomilehto, Jaakko
AU - Mohan, Viswanathan
AU - Christensen, Dirk L.
AU - Kaduka, Lydia
AU - Dekker, Jacqueline M.
AU - Nijpels, Giel
AU - Stehouwer, Coen D A
AU - Lantieri, Olivier
AU - Fujimoto, Wilfred Y.
AU - Leonetti, Donna L.
AU - McNeely, Marguerite J.
AU - Borch-Johnsen, Knut
AU - Boyko, Edward J.
AU - Vistisen, Dorte
AU - Balkau, Beverley
N1 - Funding Information:
Acknowledgements The DETECT-2 project was undertaken on the initiative of the World Health Organization and the International Diabetes Federation. DETECT-2: Task Group. Stephen Colagiuri and Crystal M. Y. Lee (Australia), Knut Borch-Johnsen and Dorte Vistisen (Denmark), Beverley Balkau (France), Jacqueline M. Dekker (the Netherlands). Crystal M. Y. Lee was supported by an Australian National Health and Medical Research Council Training Fellowship. Soraya Soulimane was supported by a PhD grant from Paris-Sud University, France. Jonathan E. Shaw was supported by an Australian National Health and Medical Research Council Senior Research Fellowship. Dirk L. Christensen was supported by a DANIDA grant and by a grant from the Cluster of International Health, University of Copenhagen.
PY - 2014/1
Y1 - 2014/1
N2 - Aims/Hypothesis: The relationships between smoking and glycaemic variables have not been well explored. We compared HbA1c, fasting plasma glucose (FPG) and 2 h plasma glucose (2H-PG) in current, ex- and never-smokers. Methods: This meta-analysis used individual data from 16,886 men and 18,539 women without known diabetes in 12 DETECT-2 consortium studies and in the French Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) and Telecom studies. Means of three glycaemic variables in current, ex- and never-smokers were modelled by linear regression, with study as a random factor. The I 2 statistic was used to evaluate heterogeneity among studies. Results: HbA1c was 0.10% (95% CI 0.08, 0.12) (1.1 mmol/mol [0.9, 1.3]) higher in current smokers and 0.03% (0.01, 0.05) (0.3 mmol/mol [0.1, 0.5]) higher in ex-smokers, compared with never-smokers. For FPG, there was no significant difference between current and never-smokers (-0.004 mmol/l [-0.03, 0.02]) but FPG was higher in ex-smokers (0.12 mmol/l [0.09, 0.14]). In comparison with never-smokers, 2H-PG was lower (-0.44 mmol/l [-0.52, -0.37]) in current smokers, with no difference for ex-smokers (0.02 mmol/l [-0.06, 0.09]). There was a large and unexplained heterogeneity among studies, with I 2 always above 50%; I 2 was little changed after stratification by sex and adjustment for age and BMI. In this study population, current smokers had a prevalence of diabetes that was 1.30% higher as screened by HbA1c and 0.52% lower as screened by 2H-PG, in comparison with never-smokers. Conclusion/interpretation: Across this heterogeneous group of studies, current smokers had a higher HbA1c and lower 2H-PG than never-smokers. This will affect the chances of smokers being diagnosed with diabetes.
AB - Aims/Hypothesis: The relationships between smoking and glycaemic variables have not been well explored. We compared HbA1c, fasting plasma glucose (FPG) and 2 h plasma glucose (2H-PG) in current, ex- and never-smokers. Methods: This meta-analysis used individual data from 16,886 men and 18,539 women without known diabetes in 12 DETECT-2 consortium studies and in the French Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) and Telecom studies. Means of three glycaemic variables in current, ex- and never-smokers were modelled by linear regression, with study as a random factor. The I 2 statistic was used to evaluate heterogeneity among studies. Results: HbA1c was 0.10% (95% CI 0.08, 0.12) (1.1 mmol/mol [0.9, 1.3]) higher in current smokers and 0.03% (0.01, 0.05) (0.3 mmol/mol [0.1, 0.5]) higher in ex-smokers, compared with never-smokers. For FPG, there was no significant difference between current and never-smokers (-0.004 mmol/l [-0.03, 0.02]) but FPG was higher in ex-smokers (0.12 mmol/l [0.09, 0.14]). In comparison with never-smokers, 2H-PG was lower (-0.44 mmol/l [-0.52, -0.37]) in current smokers, with no difference for ex-smokers (0.02 mmol/l [-0.06, 0.09]). There was a large and unexplained heterogeneity among studies, with I 2 always above 50%; I 2 was little changed after stratification by sex and adjustment for age and BMI. In this study population, current smokers had a prevalence of diabetes that was 1.30% higher as screened by HbA1c and 0.52% lower as screened by 2H-PG, in comparison with never-smokers. Conclusion/interpretation: Across this heterogeneous group of studies, current smokers had a higher HbA1c and lower 2H-PG than never-smokers. This will affect the chances of smokers being diagnosed with diabetes.
KW - 2H-PG
KW - FPG
KW - HbA
KW - Meta-analysis
KW - Smoking
UR - http://www.scopus.com/inward/record.url?scp=84890917347&partnerID=8YFLogxK
U2 - 10.1007/s00125-013-3058-y
DO - 10.1007/s00125-013-3058-y
M3 - Article
C2 - 24065153
AN - SCOPUS:84890917347
VL - 57
SP - 30
EP - 39
JO - Diabetologia
JF - Diabetologia
SN - 0012-186X
IS - 1
ER -